Karen S Lynch Cvs Health Corp (CVS) insider trading activity

Karen S Lynch is President and CEO of CVS HEALTH Corp. Currently has a direct ownership of 74,687 shares of CVS, which is worth approximately $3.3 Million. The most recent transaction as insider was on Apr 01, 2024, when has been sold 61,953 shares (Common Stock) at a price of $79.56 per share, resulting in proceeds of $4,928,980. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.7K

0% 3M change

82.69% 12M change

Total Value Held $3.3 Million

Karen S Lynch Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	SELL Payment of exercise price or tax liability	$4,928,980 $79.56 p/Share	61,953 Reduced 45.34%	74,687 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	$3,599,930 $79.56 p/Share	45,248 Added 50.0%	45,248 Common Stock (restricted)
Feb 12 2024	BUY Grant, award, or other acquisition	-	136,640 Added 50.0%	136,640 Common Stock
May 03 2023	BUY Open market or private purchase	$976,500 $69.75 p/Share	14,000 Added 3.14%	431,392 Common Stock (By Trust)
Apr 01 2023	SELL Payment of exercise price or tax liability	$6,961,137 $74.31 p/Share	93,677 Reduced 45.34%	112,933 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	206,610 Added 50.0%	206,610 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$11,821,464 $101.09 p/Share	116,940 Reduced 35.76%	210,090 Common Stock
Feb 21 2022	BUY Grant, award, or other acquisition	-	257,916 Added 44.09%	327,030 Common Stock
Nov 28 2021	SELL Payment of exercise price or tax liability	$1,292,354 $91.52 p/Share	14,121 Reduced 16.97%	69,114 Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$3,210,577 $74.3 p/Share	43,211 Reduced 45.34%	52,091 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	95,302 Added 50.0%	95,302 Common Stock
Dec 02 2020	SELL Payment of exercise price or tax liability	$889,802 $69.63 p/Share	12,779 Reduced 11.93%	94,370 Common Stock
Feb 18 2020	SELL Payment of exercise price or tax liability	-	14,215 Reduced 15.26%	78,966 Common Stock
Dec 02 2019	SELL Payment of exercise price or tax liability	$965,378 $75.55 p/Share	12,778 Reduced 18.25%	57,235 Common Stock
Nov 18 2019	SELL Open market or private sale	$6,010,725 $75.0 p/Share	80,143 Reduced 65.7%	41,831 Common Stock
Feb 19 2019	SELL Payment of exercise price or tax liability	$2,558,796 $69.88 p/Share	36,617 Reduced 23.09%	121,974 Common Stock
Dec 02 2018	SELL Payment of exercise price or tax liability	$1,038,531 $79.52 p/Share	13,060 Reduced 14.36%	77,869 Common Stock
Nov 28 2018	BUY Grant, award, or other acquisition	$18,651,456 $80.27 p/Share	232,359 Added 50.0%	232,359 Common Stock (restricted)
Nov 28 2018	BUY Grant, award, or other acquisition	-	62,747 Added 50.0%	62,747 Common Stock

Also insider at

USB

US BANCORP \DE\ Financial Services

Director

KSL

Karen S Lynch

President and CEO

Woonsocket, RI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Value

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS

Account